Everand Logo

Welcome to Everand!

  • STAT

    Opinion: World leaders have the power to end TB. They must seize the moment

    Ending tuberculosis, the world’s deadliest infectious disease, is doable, but by no means easy.
    by Eric Goosby and Michel Kazatchkine Mar 27, 2018 3 minutes
    Patients infected with multidrug-resistant tuberculosis wait to be seen at the Doctors Without Borders HIV-AIDS clinic in Yangon, Myanmar. Globally in 2016, an estimated 600,000 people developed MDR-TB.

    Attention from global leaders to ending tuberculosis, the world’s deadliest infectious disease, is growing. And that’s very good news. As we mark World TB Day and eagerly await a U.N. meeting on TB in September, we must work to sustain this commitment and build upon it to truly achieve a TB-free world.

    This is doable, but by no means easy. TB claims despite being curable for the vast majority of people who contract it.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
    Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
    Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

    Related Books & Audiobooks